Importer of Controlled Substances Application: Restek Corporation, 67363-67368 [2023-21404]

Download as PDF 67363 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices The company plans to bulk manufacture the listed controlled substances for DEA exempted certified reference materials. In-house synthesis gives access to compounds that are difficult to source. No other activities for these drug codes are authorized for this registration. Claude Redd, Acting Deputy Assistant Administrator. [FR Doc. 2023–21401 Filed 9–28–23; 8:45 am] BILLING CODE P of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 30, 2023. Such persons may also file a written request for a hearing on the application on or before October 30, 2023. DATES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not ADDRESSES: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1277] Importer of Controlled Substances Application: Restek Corporation Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Restek Corporation has applied to be registered as an importer SUMMARY: instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on August 24, 2023, Restek Corporation, 110 Benner Circle, Bellefonte, Pennsylvania 16823–8433, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code Amineptine ....................................................................................................................................................................... Mesocarb ......................................................................................................................................................................... 3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. 4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. Para-Methoxymethamphetamine (PMMA), 1-(4–1245 I N methoxyphenyl)-N-methylpropan-2-amine .......................... Pentedrone (a-methylaminovalerophenone) ................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone ..................................................................................................................... 4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- 1478 I N amine) ...................................................................... N,N-Dimethylamphetamine .............................................................................................................................................. Fenethylline ..................................................................................................................................................................... Aminorex .......................................................................................................................................................................... 4-Methylaminorex (cis isomer) ........................................................................................................................................ 4,4′-Dimethylaminorex ..................................................................................................................................................... Methylphenidate .............................................................................................................................................................. Gamma Hydroxybutyric Acid ........................................................................................................................................... Methaqualone .................................................................................................................................................................. Mecloqualone .................................................................................................................................................................. JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................ AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ............................................... JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................... FUB–AMB, MMB- FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3methylbutanoate). AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................. 5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ........................ AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 5F–ADB, 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...... ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................... 5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .............................. VerDate Sep<11>2014 21:46 Sep 28, 2023 Jkt 259001 PO 00000 Frm 00139 Fmt 4703 Sfmt 4703 E:\FR\FM\29SEN1.SGM 29SEN1 Schedule 1219 1227 1233 1235 1237 1238 1245 1246 1248 1249 1258 1475 1478 1480 1503 1585 1590 1595 1724 2010 2565 2572 6250 7008 7010 7011 7012 7014 7019 7020 7021 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 7023 7024 7025 7031 7032 7033 7034 7035 7036 7041 I I I I I I I I I I 67364 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate). 4F–MDMB–BINACA (4F–MDMB–BUTINACA or methyl 2- (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) 7043 I N. MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ........ FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole3-carboximide). APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ............................................................ 5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .................................. JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) .................... 5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ............... 4–CN–CUML–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide). SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ................................................................... JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate .......................................................... PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 4-methyl-alpha-ethylaminopentiophenone (4–MEAP) 7245 I N 4–MEAP ...................................................................... N-ethylhexedrone 7246 I N ............................................................................................................................................. Alpha-ethyltryptamine ...................................................................................................................................................... Ibogaine ........................................................................................................................................................................... 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) ....................................................................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... Lysergic acid diethylamide .............................................................................................................................................. 2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ............................................................................................... Marihuana Extract ........................................................................................................................................................... Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Parahexyl ......................................................................................................................................................................... Mescaline ......................................................................................................................................................................... 2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) .......................................................................................... 3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 2,5-Dimethoxyamphetamine ............................................................................................................................................ JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 3,4-Methylenedioxyamphetamine .................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. Peyote .............................................................................................................................................................................. 5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ Alpha-methyltryptamine ................................................................................................................................................... Bufotenine ........................................................................................................................................................................ Diethyltryptamine ............................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... Psilocybin ......................................................................................................................................................................... Psilocyn ........................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ............................................................................................ 4´-methyl-alpha-pyrrolidinohexiophenone (MPHP) .......................................................................................................... N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ N-Methyl-3-piperidyl benzilate ......................................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... 4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ..................................................................................................... 2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .................................................................................................. 2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ..................................................................................................... VerDate Sep<11>2014 21:46 Sep 28, 2023 Jkt 259001 PO 00000 Frm 00140 Fmt 4703 Sfmt 4703 E:\FR\FM\29SEN1.SGM 29SEN1 Schedule 7042 I 7043 I 7044 7047 I I 7048 7049 7081 7083 7085 7089 I I I I I I 7104 7118 7122 7144 7173 7200 7201 7203 7221 7222 7225 7245 7246 7249 7260 7286 7297 7298 7315 7348 7350 7360 7370 7374 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7415 7431 7432 7433 7434 7435 7437 7438 7439 7443 7446 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 67365 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code 2C–H 2-(2,5-Dimethoxyphenyl) ethanamine) .................................................................................................................. 2C–I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ......................................................................................................... 2C–C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ................................................................................................... 2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) .................................................................................................... 2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ............................................................................................. 2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) .................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .................................................... 25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .................................................... 25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ......................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ..................................................... alpha-pyrrolidinohexanophenone (a-PHP) ...................................................................................................................... alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... Ethylone ........................................................................................................................................................................... alpha-pyrrolidinoheptaphenone (PV8) ............................................................................................................................. AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... Acetyldihydrocodeine ....................................................................................................................................................... Benzylmorphine ............................................................................................................................................................... Codeine-N-oxide .............................................................................................................................................................. Cyprenorphine ................................................................................................................................................................. Desomorphine ................................................................................................................................................................. Etorphine (except HCl) .................................................................................................................................................... Codeine methylbromide ................................................................................................................................................... Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4–4l)1,3-dihydro-2H-benzo[d]imidazol-2-one) ................................. Dihydromorphine ............................................................................................................................................................. Difenoxin .......................................................................................................................................................................... Heroin .............................................................................................................................................................................. Hydromorphinol ............................................................................................................................................................... Methyldesorphine ............................................................................................................................................................ Methyldihydromorphine ................................................................................................................................................... Morphine methylbromide ................................................................................................................................................. Morphine methylsulfonate ............................................................................................................................................... Morphine-N-oxide ............................................................................................................................................................ Myrophine ........................................................................................................................................................................ Nicocodeine ..................................................................................................................................................................... Nicomorphine ................................................................................................................................................................... Normorphine .................................................................................................................................................................... Pholcodine ....................................................................................................................................................................... Thebacon ......................................................................................................................................................................... Acetorphine ...................................................................................................................................................................... Drotebanol ....................................................................................................................................................................... U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .................................................................................................. Acetylmethadol ................................................................................................................................................................ Allylprodine ...................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... Alphameprodine ............................................................................................................................................................... Alphamethadol ................................................................................................................................................................. Benzethidine .................................................................................................................................................................... Betacetylmethadol ........................................................................................................................................................... Betameprodine ................................................................................................................................................................ Betamethadol ................................................................................................................................................................... Betaprodine ..................................................................................................................................................................... Clonitazene ...................................................................................................................................................................... Dextromoramide .............................................................................................................................................................. Isotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) ............................ Diampromide ................................................................................................................................................................... Diethylthiambutene .......................................................................................................................................................... Dimenoxadol .................................................................................................................................................................... Dimepheptanol ................................................................................................................................................................. Dimethylthiambutene ....................................................................................................................................................... Dioxaphetyl butyrate ........................................................................................................................................................ Dipipanone ....................................................................................................................................................................... Ethylmethylthiambutene .................................................................................................................................................. Etonitazene ...................................................................................................................................................................... Etoxeridine ....................................................................................................................................................................... Furethidine ....................................................................................................................................................................... Hydroxypethidine ............................................................................................................................................................. Ketobemidone .................................................................................................................................................................. VerDate Sep<11>2014 21:46 Sep 28, 2023 Jkt 259001 PO 00000 Frm 00141 Fmt 4703 Sfmt 4703 E:\FR\FM\29SEN1.SGM 29SEN1 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7543 7544 7545 7546 7547 7548 7694 9051 9052 9053 9054 9055 9056 9070 9098 9145 9168 9200 9301 9302 9304 9305 9306 9307 9308 9309 9312 9313 9314 9315 9319 9335 9547 9551 9560 9601 9602 9603 9604 9605 9606 9607 9608 9609 9611 9612 9613 9614 9615 9616 9617 9618 9619 9621 9622 9623 9624 9625 9626 9627 9628 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 67366 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code Levomoramide ................................................................................................................................................................. Levophenacylmorphan .................................................................................................................................................... Morpheridine .................................................................................................................................................................... Noracymethadol ............................................................................................................................................................... Norlevorphanol ................................................................................................................................................................ Normethadone ................................................................................................................................................................. Norpipanone .................................................................................................................................................................... Phenadoxone ................................................................................................................................................................... Phenampromide .............................................................................................................................................................. Phenoperidine .................................................................................................................................................................. Piritramide ........................................................................................................................................................................ Proheptazine .................................................................................................................................................................... Properidine ...................................................................................................................................................................... Racemoramide ................................................................................................................................................................ Trimeperidine ................................................................................................................................................................... Phenomorphan ................................................................................................................................................................ Propiram .......................................................................................................................................................................... 1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. Tilidine ............................................................................................................................................................................. Butonitazene .................................................................................................................................................................... Lunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro1H-benzimidazol-1-yl)ethan-1- amine) ......................................... Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine ................................... N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1Hbenzimidazole) ..... Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) ................................. Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 1H-benzimidazol-1- yl)ethan-1-amine) .................................... Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)- 1Hbenzimidazol-1-yl)-N,N-diethylethan-1- amine) ............................ Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. Para-Fluorofentanyl ......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ....................................................................................... Para-Methylfentanyl (N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide; also known as 4methylfentanyl). 4’-Methyl acetyl fentanyl (N-(1-(4- methylphenethyl)piperidin-4-yl)-N-phenylacetamide) ............................................... Ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) ......... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... Butyryl Fentanyl ............................................................................................................................................................... Para-fluorobutyryl fentanyl ............................................................................................................................................... 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ......................................................................................... Para-chloroisobutyryl fentanyl ......................................................................................................................................... Isobutyryl fentanyl ............................................................................................................................................................ Beta-hydroxyfentanyl ....................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ Alpha-methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. Thiofentanyl ..................................................................................................................................................................... Beta-hydroxythiofentanyl ................................................................................................................................................. Para-methoxybutyryl fentanyl .......................................................................................................................................... Ocfentanil ......................................................................................................................................................................... Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl; thiophene fentanyl). Valeryl fentanyl ................................................................................................................................................................ Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylbenzamide; also known as benzoyl fentanyl) .......................... Beta’-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- diphenylpropanamide; also known as b’-phenyl fentanyl; 3phenylpropanoyl fentanyl). N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .......................................................................... Crotonyl fentanyl ((E–N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) ................................................................ Cyclopropyl Fentanyl ....................................................................................................................................................... Cyclopentyl fentanyl ........................................................................................................................................................ Ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl). Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ..................................................................................... Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- yl)(phenyl)carbamate) ................................................................... Ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide) ............................................. Ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) ................................ Para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide) .......................... 2’-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2’-fluoro 2- fluorofentanyl). Beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl)propionamide; also known as b-methyl fentanyl) Zipeprol ............................................................................................................................................................................ VerDate Sep<11>2014 21:46 Sep 28, 2023 Jkt 259001 PO 00000 Frm 00142 Fmt 4703 Sfmt 4703 E:\FR\FM\29SEN1.SGM 29SEN1 Schedule 9629 9631 9632 9633 9634 9635 9636 9637 9638 9641 9642 9643 9644 9645 9646 9647 9649 9661 9663 9750 9751 9756 9757 9758 9759 9764 9765 9811 9812 9813 9814 9815 9816 9817 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 9819 9820 9821 9822 9823 9824 9825 9826 9827 9830 9831 9832 9833 9834 9835 9836 9837 9838 9839 I I I I I I I I I I I I I I I I I I I 9840 9841 9842 I I I 9843 9844 9845 9847 9848 I I I I I 9850 9851 9852 9853 9854 9855 I I I I I I 9856 9873 I I 67367 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code Amphetamine ................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Lisdexamfetamine ............................................................................................................................................................ Phenmetrazine ................................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration Nabilone ........................................................................................................................................................................... 1-Phenylcyclohexylamine ................................................................................................................................................ Phencyclidine ................................................................................................................................................................... ANPP (4-Anilino-N-phenethyl-4-piperidine) ..................................................................................................................... Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) ................................................................................................. Phenylacetone ................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ Alphaprodine .................................................................................................................................................................... Anileridine ........................................................................................................................................................................ Coca Leaves .................................................................................................................................................................... Cocaine ............................................................................................................................................................................ Codeine ........................................................................................................................................................................... Etorphine HCl .................................................................................................................................................................. Dihydrocodeine ................................................................................................................................................................ Oxycodone ....................................................................................................................................................................... Hydromorphone ............................................................................................................................................................... Diphenoxylate .................................................................................................................................................................. Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Hydrocodone ................................................................................................................................................................... Levomethorphan .............................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Isomethadone .................................................................................................................................................................. Meperidine ....................................................................................................................................................................... Meperidine intermediate-A .............................................................................................................................................. Meperidine intermediate-B .............................................................................................................................................. Meperidine intermediate-C .............................................................................................................................................. Metazocine ...................................................................................................................................................................... Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl {time})amine fumarate). Methadone ....................................................................................................................................................................... Methadone intermediate .................................................................................................................................................. Metopon ........................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Morphine .......................................................................................................................................................................... Oripavine ......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Dihydroetorphine ............................................................................................................................................................. Opium, raw ...................................................................................................................................................................... Opium extracts ................................................................................................................................................................ Opium fluid extract .......................................................................................................................................................... Opium tincture ................................................................................................................................................................. Opium, powdered ............................................................................................................................................................ Opium, granulated ........................................................................................................................................................... Levo-alphacetylmethadol ................................................................................................................................................. Opium poppy ................................................................................................................................................................... Oxymorphone .................................................................................................................................................................. Noroxymorphone ............................................................................................................................................................. Poppy Straw Concentrate ............................................................................................................................................... Phenazocine .................................................................................................................................................................... Thiafentanil ...................................................................................................................................................................... Piminodine ....................................................................................................................................................................... Racemethorphan ............................................................................................................................................................. Racemorphan .................................................................................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tapentadol ....................................................................................................................................................................... Bezitramide ...................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... Moramide-intermediate .................................................................................................................................................... VerDate Sep<11>2014 21:46 Sep 28, 2023 Jkt 259001 PO 00000 Frm 00143 Fmt 4703 Sfmt 4703 E:\FR\FM\29SEN1.SGM 29SEN1 Schedule 1100 1105 1205 1631 2125 2270 2315 2550 7365 7379 7460 7471 8333 8366 8501 8603 9010 9020 9040 9041 9050 9059 9120 9143 9150 9170 9180 9190 9193 9210 9220 9226 9230 9232 9233 9234 9240 9245 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II 9250 9254 9260 9273 9300 9330 9333 9334 9600 9610 9620 9630 9639 9640 9648 9650 9652 9668 9670 9715 9729 9730 9732 9733 9737 9739 9740 9743 9780 9800 9801 9802 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II 67368 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices The company plans to import analytical reference standards for distribution to its customers for research and analytics purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized in 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Claude Redd, Acting Deputy Assistant Administrator. [FR Doc. 2023–21404 Filed 9–28–23; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on August 25, 2023, Cambridge Isotope Laboratories, Inc. 50 Frontage Road, Andover, Massachusetts 01810–5413, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Drug Enforcement Administration Controlled substance [Docket No. DEA–1274] Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc. Gamma Hydroxybutyric Acid. Tetrahydrocannabinols Morphine ....................... Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 30, 2023. Such persons may also file a written request for a hearing on the application on or before October 30, 2023. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 21:46 Sep 28, 2023 Jkt 259001 Drug code Schedule 2010 I 7370 9300 I II The company plans to import the listed controlled substances for preparation of analytical standards and formulations. In reference to drug codes 7370 (Tetrahydrocannabinols), the company plans to import a synthetic Tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Claude Redd, Acting Deputy Assistant Administrator. [FR Doc. 2023–21402 Filed 9–28–23; 8:45 am] BILLING CODE P DEPARTMENT OF LABOR Agency Information Collection Activities; Submission for OMB Review; Comment Request; Formaldehyde Standard Notice of availability; request for comments. ACTION: PO 00000 Frm 00144 Fmt 4703 Sfmt 4703 The Department of Labor (DOL) is submitting this Occupational Safety & Health Administration (OSHA)sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that the agency receives on or before October 30, 2023. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Comments are invited on: (1) whether the collection of information is necessary for the proper performance of the functions of the Department, including whether the information will have practical utility; (2) the accuracy of the agency’s estimates of the burden and cost of the collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility and clarity of the information collection; and (4) ways to minimize the burden of the collection of information on those who are to respond, including the use of automated collection techniques or other forms of information technology. FOR FURTHER INFORMATION CONTACT: Nicole Bouchet by telephone at 202– 693–0213, or by email at DOL_PRA_ PUBLIC@dol.gov. SUPPLEMENTARY INFORMATION: The Formaldehyde Standard and its collections of information are designed to provide protection for workers from the adverse health effects associated with occupational exposure to formaldehyde. The Standard requires employers to monitor worker exposure and provide notification to workers of their exposure. Employers are required to make available medical surveillance to workers. For additional substantive information about this ICR, see the related notice published in the Federal Register on June 28, 2023 (88 FR 41984). This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless the OMB approves it and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of SUMMARY: E:\FR\FM\29SEN1.SGM 29SEN1

Agencies

[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Pages 67363-67368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21404]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1277]


Importer of Controlled Substances Application: Restek Corporation

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Restek Corporation has applied to be registered as an importer 
of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY 
INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
October 30, 2023. Such persons may also file a written request for a 
hearing on the application on or before October 30, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on August 24, 2023, Restek Corporation, 110 Benner 
Circle, Bellefonte, Pennsylvania 16823-8433, applied to be registered 
as an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Amineptine...............................            1219  I
Mesocarb.................................            1227  I
3-Fluoro-N-methylcathinone (3-FMC).......            1233  I
Cathinone................................            1235  I
Methcathinone............................            1237  I
4-Fluoro-N-methylcathinone (4-FMC).......            1238  I
Para-Methoxymethamphetamine (PMMA), 1-(4-            1245  I
 1245 I N methoxyphenyl)-N-methylpropan-2-
 amine.
Pentedrone (a-methylaminovalerophenone)..            1246  I
Mephedrone (4-Methyl-N-methylcathinone...            1248  I
4-Methyl-N-ethylcathinone (4-MEC)........            1249  I
Naphyrone................................            1258  I
N-Ethylamphetamine.......................            1475  I
Methiopropamine (N-methyl-1-(thiophen-2-             1478  I
 yl)propan-2- 1478 I N amine).
N,N-Dimethylamphetamine..................            1480  I
Fenethylline.............................            1503  I
Aminorex.................................            1585  I
4-Methylaminorex (cis isomer)............            1590  I
4,4'-Dimethylaminorex....................            1595  I
Methylphenidate..........................            1724  I
Gamma Hydroxybutyric Acid................            2010  I
Methaqualone.............................            2565  I
Mecloqualone.............................            2572  I
JWH-250 (1-Pentyl-3-(2-                              6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1-                      7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-             7010  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-              7011  I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-                  7012  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-              7014  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)..            7019  I
MDMB-FUBINACA (Methyl 2-(1-(4-                       7020  I
 fluorobenzyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
FUB-AMB, MMB- FUBINACA, AMB-FUBINACA (2-             7021  I
 (1-(4-fluorobenzyl)-1Hindazole-3-
 carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-           7023  I
 2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-            7024  I
 3-yl](naphthalen-1-yl)methanone).
5F-AB-PINACA (N-(1-amino-3-methyl-1-                 7025  I
 oxobutan-2-yl)-1-(5-fluropentyl)-1H-
 indazole-3-carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1-                  7031  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-              7032  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-             7033  I
 indazole-3-carboxamido)-3-
 methylbutanoate).
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-              7034  I
 fluoropentyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-               7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5-                       7036  I
 fluoropentyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5-                        7041  I
 fluoropentyl)-1H-indole-3-carboxamido)-
 3,3-dimethylbutanoate).

[[Page 67364]]

 
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-              7042  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanoate).
4F-MDMB-BINACA (4F-MDMB-BUTINACA or                  7043  I
 methyl 2- (1-(4-fluorobutyl)-1H-indazole-
 3-carboxamido)-3,3- dimethylbutanoate)
 7043 I N.
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-                 7044  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4-                  7047  I
 FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-
 fluorobenzyl)-1H-indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-                7048  I
 pentyl-1H-indazole-3-carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-            7049  I
 1-(5-fluoropentyl)-1H-indazole-3-
 carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-                           7081  I
 methoxynaphthoyl) indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5-                       7083  I
 fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-
 indazole-3-carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-            7085  I
 phenylpropan-2-yl)-1H-pyrrolo[2,3-
 b]pyridine-3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-                   7089  I
 BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-
 BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-
 phenylpropan-2-yl)-1H-indazole-3-
 carboxamide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-             7104  I
 [(4-methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3-           7118  I
 (1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-                     7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-             7144  I
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)..            7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-            7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-                     7201  I
 naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2-                              7203  I
 chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-               7221  I
 fluoropentyl)-1H-indole-3-carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-           7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-                        7225  I
 fluoropentyl)-1H-indole-3-carboxylate).
4-methyl-alpha-ethylaminopentiophenone (4-           7245  I
 MEAP) 7245 I N 4-MEAP.
N-ethylhexedrone 7246 I N................            7246  I
Alpha-ethyltryptamine....................            7249  I
Ibogaine.................................            7260  I
2-(ethylamino)-2-(3-                                 7286  I
 methoxyphenyl)cyclohexan-1-one
 (methoxetamine).
CP-47,497 (5-(1,1-Dimethylheptyl)-2-                 7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-                      7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide...............            7315  I
2C-T-7 (2,5-Dimethoxy-4-(n)-                         7348  I
 propylthiophenethylamine.
Marihuana Extract........................            7350  I
Marihuana................................            7360  I
Tetrahydrocannabinols....................            7370  I
Parahexyl................................            7374  I
Mescaline................................            7381  I
2C-T-2 (2-(4-Ethylthio-2,5-                          7385  I
 dimethoxyphenyl) ethanamine ).
3,4,5-Trimethoxyamphetamine..............            7390  I
4-Bromo-2,5-dimethoxyamphetamine.........            7391  I
4-Bromo-2,5-dimethoxyphenethylamine......            7392  I
4-Methyl-2,5-dimethoxyamphetamine........            7395  I
2,5-Dimethoxyamphetamine.................            7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-                     7398  I
 naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine.........            7399  I
3,4-Methylenedioxyamphetamine............            7400  I
5-Methoxy-3,4-methylenedioxyamphetamine..            7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine..            7402  I
3,4-Methylenedioxy-N-ethylamphetamine....            7404  I
3,4-Methylenedioxymethamphetamine........            7405  I
4-Methoxyamphetamine.....................            7411  I
Peyote...................................            7415  I
5-Methoxy-N-N-dimethyltryptamine.........            7431  I
Alpha-methyltryptamine...................            7432  I
Bufotenine...............................            7433  I
Diethyltryptamine........................            7434  I
Dimethyltryptamine.......................            7435  I
Psilocybin...............................            7437  I
Psilocyn.................................            7438  I
5-Methoxy-N,N-diisopropyltryptamine......            7439  I
4-chloro-alpha-pyrrolidinovalerophenone              7443  I
 (4-chloro-a-PVP).
4[acute]-methyl-alpha-                               7446  I
 pyrrolidinohexiophenone (MPHP).
N-Ethyl-1-phenylcyclohexylamine..........            7455  I
1-(1-Phenylcyclohexyl)pyrrolidine........            7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine....            7470  I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine...            7473  I
N-Ethyl-3-piperidyl benzilate............            7482  I
N-Methyl-3-piperidyl benzilate...........            7484  I
N-Benzylpiperazine.......................            7493  I
4-MePPP (4-Methyl-                                   7498  I
 alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl)               7508  I
 ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)                7509  I
 ethanamine).

[[Page 67365]]

 
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine).            7517  I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl)                  7518  I
 ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl)                7519  I
 ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl)               7521  I
 ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-                        7524  I
 propylphenyl) ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5-                     7532  I
 dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)....            7535  I
25B-NBOMe (2-(4-bromo-2,5-                           7536  I
 dimethoxyphenyl)-N-(2-methoxybenzyl)
 ethanamine).
25C-NBOMe (2-(4-chloro-2,5-                          7537  I
 dimethoxyphenyl)-N-(2-methoxybenzyl)
 ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-           7538  I
 N-(2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N-                     7540  I
 methylcathinone).
Butylone.................................            7541  I
Pentylone................................            7542  I
N-Ethypentylone, ephylone (1-(1,3-                   7543  I
 benzodioxol-5-yl)-2-(ethylamino)-pentan-
 1-one).
alpha-pyrrolidinohexanophenone (a-PHP)...            7544  I
alpha-pyrrolidinopentiophenone ([alpha]-             7545  I
 PVP).
alpha-pyrrolidinobutiophenone ([alpha]-              7546  I
 PBP).
Ethylone.................................            7547  I
alpha-pyrrolidinoheptaphenone (PV8)......            7548  I
AM-694 (1-(5-Fluoropentyl)-3-(2-                     7694  I
 iodobenzoyl) indole).
Acetyldihydrocodeine.....................            9051  I
Benzylmorphine...........................            9052  I
Codeine-N-oxide..........................            9053  I
Cyprenorphine............................            9054  I
Desomorphine.............................            9055  I
Etorphine (except HCl)...................            9056  I
Codeine methylbromide....................            9070  I
Brorphine (1-(1-(1-(4-                               9098  I
 bromophenyl)ethyl)piperidin-4-4l)1,3-
 dihydro-2H-benzo[d]imidazol-2-one).
Dihydromorphine..........................            9145  I
Difenoxin................................            9168  I
Heroin...................................            9200  I
Hydromorphinol...........................            9301  I
Methyldesorphine.........................            9302  I
Methyldihydromorphine....................            9304  I
Morphine methylbromide...................            9305  I
Morphine methylsulfonate.................            9306  I
Morphine-N-oxide.........................            9307  I
Myrophine................................            9308  I
Nicocodeine..............................            9309  I
Nicomorphine.............................            9312  I
Normorphine..............................            9313  I
Pholcodine...............................            9314  I
Thebacon.................................            9315  I
Acetorphine..............................            9319  I
Drotebanol...............................            9335  I
U-47700 (3,4-dichloro-N-[2-                          9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                         9551  I
 dimethylamino)cyclohexylmethyl]benzamide
 )).
MT-45 (1-cyclohexyl-4-(1,2-                          9560  I
 diphenylethyl)piperazine)).
Acetylmethadol...........................            9601  I
Allylprodine.............................            9602  I
Alphacetylmethadol except levo-                      9603  I
 alphacetylmethadol.
Alphameprodine...........................            9604  I
Alphamethadol............................            9605  I
Benzethidine.............................            9606  I
Betacetylmethadol........................            9607  I
Betameprodine............................            9608  I
Betamethadol.............................            9609  I
Betaprodine..............................            9611  I
Clonitazene..............................            9612  I
Dextromoramide...........................            9613  I
Isotonotazene (N,N-diethyl-2-(2-(4                   9614  I
 isopropoxybenzyl)-5-nitro-1H-
 benzimidazol-1-yl)ethan-1-amine).
Diampromide..............................            9615  I
Diethylthiambutene.......................            9616  I
Dimenoxadol..............................            9617  I
Dimepheptanol............................            9618  I
Dimethylthiambutene......................            9619  I
Dioxaphetyl butyrate.....................            9621  I
Dipipanone...............................            9622  I
Ethylmethylthiambutene...................            9623  I
Etonitazene..............................            9624  I
Etoxeridine..............................            9625  I
Furethidine..............................            9626  I
Hydroxypethidine.........................            9627  I
Ketobemidone.............................            9628  I

[[Page 67366]]

 
Levomoramide.............................            9629  I
Levophenacylmorphan......................            9631  I
Morpheridine.............................            9632  I
Noracymethadol...........................            9633  I
Norlevorphanol...........................            9634  I
Normethadone.............................            9635  I
Norpipanone..............................            9636  I
Phenadoxone..............................            9637  I
Phenampromide............................            9638  I
Phenoperidine............................            9641  I
Piritramide..............................            9642  I
Proheptazine.............................            9643  I
Properidine..............................            9644  I
Racemoramide.............................            9645  I
Trimeperidine............................            9646  I
Phenomorphan.............................            9647  I
Propiram.................................            9649  I
1-Methyl-4-phenyl-4-propionoxypiperidine.            9661  I
1-(2-Phenylethyl)-4-phenyl-4-                        9663  I
 acetoxypiperidine.
Tilidine.................................            9750  I
Butonitazene.............................            9751  I
Lunitazene (N,N-diethyl-2-(2-(4-                     9756  I
 fluorobenzyl)-5-nitro1H-benzimidazol-1-
 yl)ethan-1- amine).
Metonitazene (N,N-diethyl-2-(2-(4-                   9757  I
 methoxybenzyl)-5-nitro-1Hbenzimidazol-1-
 yl)ethan-1-amine.
N-pyrrolidino etonitazene; etonitazepyne             9758  I
 (2-(4-ethoxybenzyl)-5-nitro-1-(2-
 (pyrrolidin-1-yl)ethyl)-1Hbenzimidazole).
Protonitazene (N,N-diethyl-2-(5-nitro-2-             9759  I
 (4-propoxybenzyl)-1H-benzimidazol-1-
 yl)ethan-1-amine).
Metodesnitazene (N,N-diethyl-2-(2-(4-                9764  I
 methoxybenzyl)- 1H-benzimidazol-1-
 yl)ethan-1-amine).
Etodesnitazene; etazene (2-(2-(4-                    9765  I
 ethoxybenzyl)- 1Hbenzimidazol-1-yl)-N,N-
 diethylethan-1- amine).
Acryl fentanyl (N-(1-phenethylpiperidin-4-           9811  I
 yl)-N-phenylacrylamide).
Para-Fluorofentanyl......................            9812  I
3-Methylfentanyl.........................            9813  I
Alpha-methylfentanyl.....................            9814  I
Acetyl-alpha-methylfentanyl..............            9815  I
N-(2-fluorophenyl)-N-(1-                             9816  I
 phenethylpiperidin-4-yl)propionamide.
Para-Methylfentanyl (N-(4-methylphenyl)-N-           9817  I
 (1- phenethylpiperidin-4-
 yl)propionamide; also known as 4-
 methylfentanyl).
4'-Methyl acetyl fentanyl (N-(1-(4-                  9819  I
 methylphenethyl)piperidin-4-yl)-N-
 phenylacetamide).
Ortho-Methyl methoxyacetyl fentanyl (2-              9820  I
 methoxy-N-(2- methylphenyl)-N-(1-
 phenethylpiperidin-4-yl)acetamide).
Acetyl Fentanyl (N-(1-phenethylpiperidin-            9821  I
 4-yl)-N-phenylacetamide).
Butyryl Fentanyl.........................            9822  I
Para-fluorobutyryl fentanyl..............            9823  I
4-Fluoroisobutyryl fentanyl (N-(4-                   9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-4-
 yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-           9825  I
 phenylacetamide.
Para-chloroisobutyryl fentanyl...........            9826  I
Isobutyryl fentanyl......................            9827  I
Beta-hydroxyfentanyl.....................            9830  I
Beta-hydroxy-3-methylfentanyl............            9831  I
Alpha-methylthiofentanyl.................            9832  I
3-Methylthiofentanyl.....................            9833  I
Furanyl fentanyl (N-(1-phenethylpiperidin-           9834  I
 4-yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl.............................            9835  I
Beta-hydroxythiofentanyl.................            9836  I
Para-methoxybutyryl fentanyl.............            9837  I
Ocfentanil...............................            9838  I
Thiofuranyl fentanyl (N-(1-                          9839  I
 phenethylpiperidin-4-yl)-
 Nphenylthiophene-2-carboxamide; also
 known as 2- thiofuranyl fentanyl;
 thiophene fentanyl).
Valeryl fentanyl.........................            9840  I
Phenyl fentanyl (N-(1-phenethylpiperidin-            9841  I
 4-yl)-Nphenylbenzamide; also known as
 benzoyl fentanyl).
Beta'-Phenyl fentanyl (N-(1-                         9842  I
 phenethylpiperidin-4-yl)-N,3-
 diphenylpropanamide; also known as
 [beta]'-phenyl fentanyl; 3-
 phenylpropanoyl fentanyl).
N-(1-phenethylpiperidin-4-yl)-N-                     9843  I
 phenyltetrahydrofuran-2-carboxamide.
Crotonyl fentanyl ((E-N-(1-                          9844  I
 phenethylpiperidin-4-yl)-N-phenylbut-2-
 enamide).
Cyclopropyl Fentanyl.....................            9845  I
Cyclopentyl fentanyl.....................            9847  I
Ortho-Methyl acetylfentanyl (N-(2-                   9848  I
 methylphenyl)-N-(1- phenethylpiperidin-4-
 yl)acetamide; also known as 2- methyl
 acetylfentanyl).
Fentanyl related-compounds as defined in             9850  I
 21 CFR 1308.11(h).
Fentanyl carbamate (ethyl (1-                        9851  I
 phenethylpiperidin-4-
 yl)(phenyl)carbamate).
Ortho-Fluoroacryl fentanyl (N-(2-                    9852  I
 fluorophenyl)-N-(1- phenethylpiperidin-4-
 yl)acrylamide).
Ortho-Fluoroisobutyryl fentanyl (N-(2-               9853  I
 fluorophenyl)-N-(1- phenethylpiperidin-4-
 yl)isobutyramide).
Para-Fluoro furanyl fentanyl (N-(4-                  9854  I
 fluorophenyl)-N-(1- phenethylpiperidin-4-
 yl)furan-2-carboxamide).
2'-Fluoro ortho-fluorofentanyl (N-(1-(2-             9855  I
 fluorophenethyl)piperidin-4-yl)-N-(2-
 fluorophenyl)propionamide; also known as
 2'-fluoro 2- fluorofentanyl).
Beta-Methyl fentanyl (N-phenyl-N-(1-(2-              9856  I
 phenylpropyl)piperidin-4-
 yl)propionamide; also known as [beta]-
 methyl fentanyl).
Zipeprol.................................            9873  I

[[Page 67367]]

 
Amphetamine..............................            1100  II
Methamphetamine..........................            1105  II
Lisdexamfetamine.........................            1205  II
Phenmetrazine............................            1631  II
Amobarbital..............................            2125  II
Pentobarbital............................            2270  II
Secobarbital.............................            2315  II
Glutethimide.............................            2550  II
Dronabinol in an oral solution in a drug             7365  II
 product approved for marketing by the
 U.S. Food and Drug Administration.
Nabilone.................................            7379  II
1-Phenylcyclohexylamine..................            7460  II
Phencyclidine............................            7471  II
ANPP (4-Anilino-N-phenethyl-4-piperidine)            8333  II
Norfentanyl (N-phenyl-N-(piperidin-4-yl)             8366  II
 propionamide).
Phenylacetone............................            8501  II
1-Piperidinocyclohexanecarbonitrile......            8603  II
Alphaprodine.............................            9010  II
Anileridine..............................            9020  II
Coca Leaves..............................            9040  II
Cocaine..................................            9041  II
Codeine..................................            9050  II
Etorphine HCl............................            9059  II
Dihydrocodeine...........................            9120  II
Oxycodone................................            9143  II
Hydromorphone............................            9150  II
Diphenoxylate............................            9170  II
Ecgonine.................................            9180  II
Ethylmorphine............................            9190  II
Hydrocodone..............................            9193  II
Levomethorphan...........................            9210  II
Levorphanol..............................            9220  II
Isomethadone.............................            9226  II
Meperidine...............................            9230  II
Meperidine intermediate-A................            9232  II
Meperidine intermediate-B................            9233  II
Meperidine intermediate-C................            9234  II
Metazocine...............................            9240  II
Oliceridine (N-[(3-methoxythiophen-                  9245  II
 2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-
 oxaspiro[4.5] decan-9-yl] ethyl
 {time{time} )amine fumarate).
Methadone................................            9250  II
Methadone intermediate...................            9254  II
Metopon..................................            9260  II
Dextropropoxyphene, bulk (non-dosage                 9273  II
 forms).
Morphine.................................            9300  II
Oripavine................................            9330  II
Thebaine.................................            9333  II
Dihydroetorphine.........................            9334  II
Opium, raw...............................            9600  II
Opium extracts...........................            9610  II
Opium fluid extract......................            9620  II
Opium tincture...........................            9630  II
Opium, powdered..........................            9639  II
Opium, granulated........................            9640  II
Levo-alphacetylmethadol..................            9648  II
Opium poppy..............................            9650  II
Oxymorphone..............................            9652  II
Noroxymorphone...........................            9668  II
Poppy Straw Concentrate..................            9670  II
Phenazocine..............................            9715  II
Thiafentanil.............................            9729  II
Piminodine...............................            9730  II
Racemethorphan...........................            9732  II
Racemorphan..............................            9733  II
Alfentanil...............................            9737  II
Remifentanil.............................            9739  II
Sufentanil...............................            9740  II
Carfentanil..............................            9743  II
Tapentadol...............................            9780  II
Bezitramide..............................            9800  II
Fentanyl.................................            9801  II
Moramide-intermediate....................            9802  II
------------------------------------------------------------------------


[[Page 67368]]

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytics purposes. 
Placement of these drug codes onto the company's registration does not 
translate into automatic approval of subsequent permit applications to 
import controlled substances. Approval of permit applications will 
occur only when the registrant's business activity is consistent with 
what is authorized in 21 U.S.C. 952(a)(2). Authorization will not 
extend to the import of Food and Drug Administration-approved or non-
approved finished dosage forms for commercial sale.

Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-21404 Filed 9-28-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.